The "vegetable lamb" plant — once believed to bear fruit that ripened into a living baby sheep — produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease.
A former Food and Drug Administration scientist said his job was eliminated after he raised concerns about the risks of radiation exposure from high-grade medical scanning.
So a scientist walks into a shopping mall to watch people laugh. There's no punchline. Laughter is a serious scientific subject, one that researchers are still trying to figure out.
Esco CelCulture CO2 Incubators provide a carefully monitored and consistent cell culture environment. VivoCell temperature, CO2 and humidity control technology with proprietary control algorithms, provides cells with a pseudo-in vivo environment by ensuring excellent accuracy and uniformity.
InVitria’s launch of Zap-Hybridoma provides a powerful solution for hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity and deliver easier purification of the target product.
Available in two sizes, the new triple gas incubators from IKS offer a high quality culturing environment with excellent temperature accuracy and CO2 stability.
Isis Pharmaceuticals Inc. said it will work with British drugmaker GlaxoSmithKline PLC to develop treatments for rare diseases in a partnership that could bring Isis almost $1.5 billion in payments.
Nikon Instruments, Inc. has unveiled its new A1R-MP Multiphoton and Confocal microscope system for high speed, high resolution and high sensitivity multiphoton excitation and confocal fluorescence imaging.
TTP LabTech’s comPOUND system consists of a high-density, self-contained, automated sample store and a suite of specialised delivery modules.
A drug already in clinical trials to treat a variety of tumors shows a remarkable ability to shut down growth of glioblastoma in both laboratory cells and in animals.
Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) remain the most common treatment to relieve symptoms of arthritis and other inflammatory disorders.
The drugmaker The Medicines Co. said it filed a federal lawsuit against several government agencies over the denial of an extension for the principal U.S. patent covering the anti-clotting drug Angiomax.
Biotechnology company Genzyme Corp. has named David Meeker to the newly created position of chief operating officer.
Critical Outcome Technologies Inc. announced positive test results today from a series of animal experiments carried out at a prominent Canadian cancer research facility with COTI-2 as a single agent against an aggressive strain of triple negative human breast cancer; MDA-MB-231-luc.
Oncolytics Biotech Inc. announced that the Cancer Therapy & Research Center at the University of Texas Health Science Center has started patient enrollment in a Phase 2 clinical trial using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel in patients with SCC lung cancer.